title: Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum.
abstract: BACKGROUND
  Recently, second-generation antipsychotics (SGAs) have been widely used in the treatment of mood disorders. However, the mechanisms of the antidepressant effect of SGAs remain unclear. We proposed that Golf protein, a stimulant alpha-subunit of G protein coupled with the dopamine D1 receptor, might a play the key role in the antidepressive effect of antidepressants. To clarify the relationship between Golf protein and the antidepressive effects of antipsychotics, we examined the effects of chronic treatment with several antipsychotics on the level of Golf protein in the rat striatum.
  
  
  METHODS
  Male Wistar rats were treated with one of several antipsychotics for 2 weeks: olanzapine (2, 5, or 10 mg/kg), sulpiride (5, 10, or 50 mg/kg), amisulpride (3, 10, or 20 mg/kg), risperidone (0.2 or 2 mg/kg), haloperidol (0.3 or 3 mg/kg), or clozapine (2 or 10 mg/kg).
  
  
  CONCLUSIONS
  Olanzapine (5 mg/kg), sulpiride (5, or 10 mg/kg), and amisulpride (10 mg/kg) treatments significantly increased the level of Golf protein, but there was no increase with administration of higher doses of these three antipsychotics. Risperidone, haloperidol, and clozapine treatment did not change the level of Golf protein at any dose. In this study, all antipsychotics that have antidepressive effects increased Golf protein. This suggests that an increase in Golf may play an important role in the antidepressive effect of antipsychotics.
  
  
  CONCLUSIONS
  We postulate that the increase in Golf protein levels result in an increase the proportion of D1 receptors in the high-affinity state and that augmentation of the dopaminergic system exerts the antidepressant effect.
authors.affiliation: Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, and Okayama Red Cross General Hospital, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan.
authors.forename: Hideki
authors.initials: H
authors.lastname: Taoka
authors.forename: Takashi
authors.initials: T
authors.lastname: Hamamura
authors.forename: Shiro
authors.initials: S
authors.lastname: Endo
authors.forename: Shinji
authors.initials: S
authors.lastname: Miyata
authors.forename: Kishio
authors.initials: K
authors.lastname: Toma
authors.forename: Takeshi
authors.initials: T
authors.lastname: Ishihara
authors.forename: Shigetoshi
authors.initials: S
authors.lastname: Kuroda
mesh_terms: D000077582:Amisulpride; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000494:pharmacology / Q000627:therapeutic use; D015153:Blotting, Western; D003024:Clozapine / Q000008:administration & dosage; D003342:Corpus Striatum / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D044385:GTP-Binding Protein alpha Subunits / Q000737:chemistry / Q000378:metabolism*; D006220:Haloperidol / Q000008:administration & dosage; D007274:Injections, Intraperitoneal; D008297:Male; D000077152:Olanzapine; D051381:Rats; D017208:Rats, Wistar; D018967:Risperidone / Q000008:administration & dosage; D013469:Sulpiride / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D014150:Antipsychotic Agents; D044385:GTP-Binding Protein alpha Subunits; C084618:olfactory G protein subunit alpha olf; D001569:Benzodiazepines; D013469:Sulpiride; D000077582:Amisulpride; D003024:Clozapine; D006220:Haloperidol; D018967:Risperidone; D000077152:Olanzapine
references.citation: J Clin Psychiatry. 2005 May;66(5):575-8
references.pmid: 15889942
references.citation: Eur J Pharmacol. 1994 Sep 1;262(1-2):107-11
references.pmid: 7813561
references.citation: Curr Psychiatry Rep. 2005 Dec;7(6):435-40
references.pmid: 16318821
references.citation: Acta Psychiatr Scand. 1993 Dec;88(6):434-9
references.pmid: 8310852
references.citation: Psychopharmacology (Berl). 1977 Aug 16;53(3):309-14
references.pmid: 408861
references.citation: J Neurosci. 2000 Aug 15;20(16):RC91
references.pmid: 10924528
references.citation: Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004362
references.pmid: 16856043
references.citation: J Clin Psychiatry. 2005 May;66(5):611-6
references.pmid: 15889948
references.citation: Am J Psychiatry. 2004 Sep;161(9):1620-5
references.pmid: 15337652
references.citation: Int Clin Psychopharmacol. 2001 Nov;16(6):317-24
references.pmid: 11712619
references.citation: J Psychopharmacol. 1999;13(3):248-54
references.pmid: 10512080
references.citation: Ann N Y Acad Sci. 1988;537:206-15
references.pmid: 3059924
references.citation: Arch Gen Psychiatry. 2003 Nov;60(11):1079-88
references.pmid: 14609883
references.citation: Pharmacol Res Commun. 1988 Dec;20(12):1121-2
references.pmid: 2905479
references.citation: Neuroscience. 1989;30(3):767-77
references.pmid: 2528080
references.citation: Psychopharmacology (Berl). 1983;81(3):258-60
references.pmid: 6417717
references.citation: J Affect Disord. 1997 Apr;43(2):95-103
references.pmid: 9165379
references.citation: N Engl J Med. 2004 Jul 29;351(5):476-86
references.pmid: 15282355
references.citation: Drugs. 2001;61(14):2123-50
references.pmid: 11735643
references.citation: J Neurosci. 1993 May;13(5):2237-48
references.pmid: 8478697
references.citation: Life Sci. 2006 Jun 27;79(5):462-8
references.pmid: 16546220
references.citation: Int Clin Psychopharmacol. 2002 Jan;17(1):27-32
references.pmid: 11800503
references.citation: J Clin Psychiatry. 2000;61 Suppl 4:33-8
references.pmid: 10739329
references.citation: Biol Psychiatry. 2006 Jun 15;59(12):1151-9
references.pmid: 16566899
references.citation: Psychopharmacology (Berl). 2002 May;161(3):263-70
references.pmid: 12021829
references.citation: J Neurochem. 2001 Mar;76(5):1585-8
references.pmid: 11238742
references.citation: Pharmacopsychiatry. 1999 Jul;32(4):127-35
references.pmid: 10505482
references.citation: Neuropsychopharmacology. 2007 May;32(5):1109-21
references.pmid: 17063155
references.citation: Eur Arch Psychiatry Clin Neurosci. 2005 Apr;255(2):83-93
references.pmid: 15812601
references.citation: Eur J Pharmacol. 1992 Jun 24;217(1):15-21
references.pmid: 1397023
references.citation: Clin Neuropharmacol. 1990;13 Suppl 1:S76-83
references.pmid: 2199037
references.citation: Brain Res. 1983 Dec;287(3):225-36
references.pmid: 6362771
references.citation: Eur J Pharmacol. 2000 Sep 29;405(1-3):365-73
references.pmid: 11033341
references.citation: Fundam Clin Pharmacol. 2004 Dec;18(6):601-7
references.pmid: 15548230
references.citation: J Clin Psychopharmacol. 1998 Dec;18(6):447-54
references.pmid: 9864076
references.citation: Int Clin Psychopharmacol. 2002 Dec;17 Suppl 4:S9-15; discussion S16-7
references.pmid: 12685917
references.citation: Neuropharmacology. 1995 Oct;34(10):1335-8
references.pmid: 8570031
references.citation: Neuropsychobiology. 2001;43(3):170-4
references.pmid: 11287796
references.citation: J Clin Psychiatry. 2005;66 Suppl 3:5-11
references.pmid: 15762829
references.citation: Am J Psychiatry. 1985 Apr;142(4):430-6
references.pmid: 3883815
references.citation: Psychopharmacology (Berl). 1994 Aug;115(4):495-501
references.pmid: 7871094
references.citation: Mol Psychiatry. 2006 Mar;11(3):227-40
references.pmid: 16432528
references.citation: N Engl J Med. 2005 Oct 27;353(17):1819-34
references.pmid: 16251538
references.citation: J Psychiatr Res. 2007 Apr-Jun;41(3-4):189-206
references.pmid: 16870212
references.citation: J Neural Transm. 1984;60(3-4):273-82
references.pmid: 6241227
references.citation: Ann Intern Med. 2007 Nov 6;147(9):593-602
references.pmid: 17975181
references.citation: J Affect Disord. 1998 Feb;48(1):47-56
references.pmid: 9495601
references.citation: Bipolar Disord. 2005;7 Suppl 5:13-23
references.pmid: 16225556
references.citation: Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004999
references.pmid: 17054229
references.citation: J Clin Psychiatry. 2005;66 Suppl 5:40-8
references.pmid: 16038601
references.citation: J Clin Psychiatry. 2005 Nov;66(11):1376-85
references.pmid: 16420074